About

Publications While At HealthPartners

selected publications

Journal Article

A comparison of continuous glucose monitoring-measured time-in-range 70-180 mg/dL versus time-in-tight-range 70-140 mg/dL. 

Diabetes Technology & Therapeutics. 2024

Continuous Glucose Monitoring-Derived Differences in Pregnancies With and Without Adverse Perinatal Outcomes. 

Obstetrics and Gynecology. 2024

Continuous glucose monitoring profiles in pregnancies with and without gestational diabetes mellitus. 

Diabetes care. 2024

Glucose levels measured with continuous glucose monitoring in uncomplicated pregnancies. 

BMJ open diabetes research & care. 2024

A comparison of continuous glucose monitoring estimated hemoglobin A1c in adults with type 1 or type 2 diabetes. 

Diabetes Technology & Therapeutics. 2023

Assessment of the glucose management indicator using different sampling durations. 

Diabetes Technology & Therapeutics. 2023

Discordance between glucose management indicator and glycated hemoglobin in people without diabetes. 

Diabetes Technology & Therapeutics. 2023

The relationship between percent time <70 mg/dL and percent time <54 mg/dL measured by continuous glucose monitoring. 

Diabetes Technology & Therapeutics. 2023

A comparison of postprandial glucose control in the Medtronic advanced hybrid closed-loop system versus 670G. 

Diabetes Technology & Therapeutics. 2022

Impact of temporary glycemic target use in the hybrid and advanced hybrid closed-loop systems. 

Diabetes Technology & Therapeutics. 2022

The optimal duration of a run-in period to initiate continuous glucose monitoring for a randomized trial. 

Diabetes Technology & Therapeutics. 2022

A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial. 

Lancet (London, England). 2021

Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial. 

JAMA. 2021

Glycaemic profiles of diverse patients with type 2 diabetes using basal insulin: MOBILE study baseline data. 

Diabetes, Obesity & Metabolism. 2021

Lived experience of advanced hybrid closed-loop versus hybrid closed-loop: patient-reported outcomes and perspectives. 

Diabetes Technology & Therapeutics. 2021

The effect of discontinuing continuous glucose monitoring in adults with type 2 diabetes treated with basal insulin. 

Diabetes care. 2021

Diabetes telehealth solutions: improving self-management through remote initiation of continuous glucose monitoring. 

Journal of the Endocrine Society. 2020

Contact

full name

P. Calhoun

Quick Info

 

Collaboration

Co-author network

Map of science